SOURCE Inovio Pharmaceuticals, Inc.
The vaccine study showed that 95% of subjects generated an Ebola-specific antibody immune response.
Seres Therapeutics, PTC Therapeutics and Inovio Pharmaceuticals were among the biotech stock movers in premarket trading on Thursday.
These heavily shorted stocks could get squeezed higher if they report positive earnings this week.
These four biotech stocks have been moving on some interesting news and clinical results.
©1996-2017 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.